Latest Ishita Drugs & Indus stock price
Ishita Drugs & Indus P/E Ratio
ISHITADR • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
24.83
Moderate Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
24.83
Current Price
₹72.00
EPS (TTM)
₹2.90
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
47.99
Sector Median
27.37
Sector Rank
#11 of 140
Sector Percentile
7.9%
Key P/E Ratio Insights for Ishita Drugs & Indus
- Trading at discount to sector average PE of 47.99
View the ISHITADR equity price for detailed stock performance.
Related Pages for Ishita Drugs & Indus
Additional stock information and data for ISHITADR
Sector P/E Ratio Comparison
Comparing Ishita Drugs & Indus with other companies in Healthcare sector
Sector Average
47.99
Sector Median
27.37
Lowest P/E
1.1
Highest P/E
754.17
Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.1 | ₹38 | Low |
| Murae Organisor | MURAE | 3.14 | ₹47 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 8.42 | ₹2,437 | Low |
| Zenith Drugs | ZENITHDRUG | 9.03 | ₹85 | Low |
| Brooks Laboratories | BROOKS | 9.44 | ₹198 | Low |